Timing and dose do not tell the same story: a reply to Wieruszewski and Khanna

• by Žiga Kalamar, Giovanni Landoni, Andrej Markota

• October 12, 2026

Closing the Interpretive Gap in Urine Drug Testing: A Call for Education and Assay Modernization

• by Dustin P. Kee, John J. Buyske, Ashish P. Thakrar

• October 13, 2026

FDA approves first therapy for symptomatic dermographism

The oral BTK inhibitor produced a complete hive response in 29.3% of treated patients at week 12.

• by Teraya Smith

• October 7, 2026

• 2 min

Realizing the value of the divergence event in clinical human-AI interaction

• by Florence X. Doo, Gabriel A. Brat, Sarah C. Rossetti, Robert Klitzman, Charles E. Binkley

• October 13, 2026